Insider filing · VKTX
Greg Zante
Chief Financial Officer
profile →
Viking Therapeutics, Inc.
VKTX · Healthcare · 22 filings in 24 months
ticker →
Greg Zante sold $710K of Viking Therapeutics (VKTX)
Executed Jul 29, disclosed Jul 30, the same day.
Value, as filed
$710K
21,217 sh × $33.47
Executed
Jul 29
the trade date, as filed
Disclosed
Jul 30
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GZGreg Zante (Chief Financial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Viking Therapeutics, Inc. (VKTX). The largest single filing was $1.8M of VKTX (56,161 sh across 3 lots, as filed), executed Jan 5.
The name
VKTXHealthcare · Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Greg Zante in VKTX
VKTXSALE
Viking Therapeutics, Inc.
$1.8M56,161 sh across 3 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $216K
6,185 sh × $35.00
Exec Oct 28 2025
Filed Oct 28 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $118K
4,266 sh × $27.76
Exec Jul 3 2025
Filed Jul 3 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $2.2M
50,309 sh across 2 lots
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $10.0M
130,481 sh across 7 lots
Exec Oct 28 2024
Filed Oct 28 2024 · 5:30 PM ET